Methylprednisolone bolus: a novel therapy for severe atopic dermatitis
- 1 March 1994
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 83 (3) , 315-317
- https://doi.org/10.1111/j.1651-2227.1994.tb18102.x
Abstract
Seven children suffering from severe atopic dermatitis, unresponsive to standard therapy, received an iv bolus dose of methylprednisolone (20 mg/kg/day) for three days. Immunological parameters were evaluated before and after treatment. At the end of bolus therapy both skin lesions and itching improved for several months in five of seven patients. No side effects were observed, but a significant and transient lymphopenic response occurred, with lower CD4 + than CD8 + lymphocyte counts. Our data suggest that this therapy may be a novel and safe therapeutic approach in severe atopic dermatitis.Keywords
This publication has 6 references indexed in Scilit:
- In vivo and in vitro effects of glucocorticoids on lectin-induced blastogenesis in atopic dermatitisArchives of Dermatological Research, 1991
- Pathogenesis of eczemaClinical and Experimental Allergy, 1990
- Production of Cytokines by Epithelial TissuesThe American Journal of Dermatopathology, 1989
- Methylprednisolone in Childhood Idiopathic Thrombocytopenic PurpuraActa Haematologica, 1988
- Diagnostic Features of Atopic DermatitisActa Dermato-Venereologica, 1980
- The Differential Effect of In Vivo Hydrocortisone on the Kinetics of Subpopulations of Human Peripheral Blood Thymus-Derived LymphocytesJournal of Clinical Investigation, 1978